Reprokine

Reprokine is a biotechnology company that develops and manufactures high-quality research reagents and therapeutic candidates focused on the cytokine and chemokine systems. Based in Rehovot, Israel, the company offers a comprehensive portfolio of recombinant proteins, antibodies, and ELISA kits used by academic and industrial researchers worldwide. Reprokine's internal R&D efforts are directed toward modulating chemokine signaling to treat conditions in reproductive medicine, oncology, and inflammation. Their therapeutic pipeline includes small molecule and peptide-based modulators of targets such as CXCR4, aimed at improving outcomes in fertility treatments and preventing cancer progression. The company leverages its deep expertise in protein engineering and immunology to provide specialized tools for the study of cell signaling and trafficking. By maintaining a dual focus on commercial reagents and drug discovery, Reprokine supports the broader life sciences community while advancing its own proprietary medical solutions.